Assertio Therapeutics Inc

Healthcare
$0.84
+0.02(2.97%) 1D
1D
1W
1M
1Y
3Y
5Y

Performance

Open PricePrev. CloseVolumeAvg. Volume
$0.84$0.81560,379256,585

Fundamentals

Market Cap$80.40M
P/B Ratio0.9
P/E Ratio-1.9
Enterprise Value$72.40M
Div. Yield0.00%
Book Value2.36
EPS(TTM)-1.46
ROE-80.60%
Understand Fundamentals

About the Company

Assertio Therapeutics, Inc. is an American pharmaceutical company and is a major supplier of products for the treatment of neurology, pain, and diseases of the central nervous system. The company was founded in the year 1995 and is listed on NASDAQ as ASRT. There are several products approved by the United States Food and Drug Administration, and the company even announced its name change from Depomed, Inc. to Assertio Therapeutics, Inc. The company is headquartered in Newark, California, as a joint venture between Elan and Depomed. The company is known to improve the bioavailability of generic drugs through the usage of polymers that are usually used in the food and cosmetics industry to reduce the side effects and lower the doses that are necessary. The company also has its diabetes treatment, Glumetza, approved for adults in the United States.;
OrganisationAssertio Therapeutics Inc

Company Financials

*All values are in Million $
No Graph Data To Display
Quarterly
Yearly

Similar Stocks

COMPANYMARKET PRICECLOSE PRICEMARKET CAP
Invest the way you want
Join millions of Indians who trust and love Groww